Terms: = Prostate cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
193 results:
1. A machine learning radiomics model based on bpMRI to predict bone metastasis in newly diagnosed prostate cancer patients.
Xinyang S; Shuang Z; Tianci S; Xiangyu H; Yangyang W; Mengying D; Jingran Z; Feng Y
Magn Reson Imaging; 2024 Apr; 107():15-23. PubMed ID: 38181835
[TBL] [Abstract] [Full Text] [Related]
2. The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples.
Sameen AM; Shabeeb IA; Rashied RM
J Med Life; 2023 Sep; 16(9):1388-1392. PubMed ID: 38107701
[TBL] [Abstract] [Full Text] [Related]
3. A Literature Review of Racial Disparities in prostate cancer Research.
Vermeille M; Koster KL; Benzaquen D; Champion A; Taussky D; Kaulanjan K; Früh M
Curr Oncol; 2023 Nov; 30(11):9886-9894. PubMed ID: 37999138
[TBL] [Abstract] [Full Text] [Related]
4. The Association between Dietary Inflammatory Potential and Urologic cancers: A Meta-analysis.
Dai YN; Yi-Wen Yu E; Zeegers MP; Wesselius A
Adv Nutr; 2024 Jan; 15(1):100124. PubMed ID: 37940476
[TBL] [Abstract] [Full Text] [Related]
5. Mobile Phone Use and Risks of Overall and 25 Site-Specific cancers: A Prospective Study from the UK Biobank Study.
Zhang Y; Zhang Y; Ye Z; Yang S; Liu M; Wu Q; Zhou C; He P; Gan X; Qin X
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):88-95. PubMed ID: 37870426
[TBL] [Abstract] [Full Text] [Related]
6. Transitional zone prostate cancer: Performance of texture-based machine learning and image-based deep learning.
Lee MS; Kim YJ; Moon MH; Kim KG; Park JH; Sung CK; Jeong H; Son H
Medicine (Baltimore); 2023 Sep; 102(39):e35039. PubMed ID: 37773806
[TBL] [Abstract] [Full Text] [Related]
7. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder cancer: United States insurance claims data.
Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
[TBL] [Abstract] [Full Text] [Related]
8. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Gallbladder cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract] [Full Text] [Related]
9. Holothurin A Inhibits runx1-Enhanced EMT in Metastasis prostate cancer via the Akt/JNK and P38 MAPK Signaling Pathway.
Janta S; Pranweerapaiboon K; Vivithanaporn P; Plubrukarn A; Chairoungdua A; Prasertsuksri P; Apisawetakan S; Chaithirayanon K
Mar Drugs; 2023 Jun; 21(6):. PubMed ID: 37367670
[TBL] [Abstract] [Full Text] [Related]
10. Radiomics based automated quality assessment for T2W prostate MR images.
Thijssen LCP; de Rooij M; Barentsz JO; Huisman HJ
Eur J Radiol; 2023 Aug; 165():110928. PubMed ID: 37354769
[TBL] [Abstract] [Full Text] [Related]
11. Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.
Fan B; Schooling CM; Zhao JV
J Hum Hypertens; 2023 Nov; 37(11):1028-1032. PubMed ID: 37117874
[TBL] [Abstract] [Full Text] [Related]
12. runx1 Is Regulated by Androgen Receptor to Promote cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast cancer.
Fernández NB; Sosa SM; Roberts JT; Recouvreux MS; Rocha-Viegas L; Christenson JL; Spoelstra NS; Couto FL; Raimondi AR; Richer JK; Rubinstein N
Cells; 2023 Jan; 12(3):. PubMed ID: 36766786
[TBL] [Abstract] [Full Text] [Related]
13. Sleep Traits, Night Shift Work and Lung cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study).
Cordina-Duverger E; Uchai S; Tvardik N; Billmann R; Martin D; Trédaniel J; Wislez M; Blons H; Laurent-Puig P; Antoine M; Guénel P; Radoï L; Welca Study Group
Int J Environ Res Public Health; 2022 Dec; 19(23):. PubMed ID: 36498320
[TBL] [Abstract] [Full Text] [Related]
14. The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI.
Song J; Zhao C; Zhang F; Yuan Y; Wang LM; Sah V; Zhang J; Weng W; Yang Z; Wang Z; Wang L
Abdom Radiol (NY); 2023 Feb; 48(2):704-712. PubMed ID: 36464756
[TBL] [Abstract] [Full Text] [Related]
15. Consequences of SARS-CoV-2 pandemic on urological surgery in France: a nationwide analysis of the healthcare system database.
Robert G; Bernhard JC; Capon G; Alezra E; Estrade V; Blanc P; Bladou F; Bensadoun H
BMJ Open; 2022 Nov; 12(11):e066220. PubMed ID: 36375970
[TBL] [Abstract] [Full Text] [Related]
16. Significance of non-standardized magnetic resonance imaging abnormalities and subsequent targeted prostate cancer biopsy for pathologists: A retrospective observational study.
Okubo Y; Yamamoto Y; Terao H; Suzuki T; Koizumi M; Yoshioka E; Washimi K; Sato S; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Dec; 240():154188. PubMed ID: 36327822
[TBL] [Abstract] [Full Text] [Related]
17. Association of triglyceride levels and prostate cancer: a Mendelian randomization study.
Zhu S; Hu X; Fan Y
BMC Urol; 2022 Oct; 22(1):167. PubMed ID: 36316671
[TBL] [Abstract] [Full Text] [Related]
18. Adolescent dietary patterns in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.
Lan T; Park Y; Colditz GA; Liu J; Wang M; Wu K; Giovannucci E; Sutcliffe S
Br J Cancer; 2023 Jan; 128(1):57-62. PubMed ID: 36316560
[TBL] [Abstract] [Full Text] [Related]
19. The Comprehensive Analysis of Hub Gene ARRB2 in prostate cancer.
Zhou B; Song H; Xu W; Zhang Y; Liu Y; Qi W
Dis Markers; 2022; 2022():8518378. PubMed ID: 36284990
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.
Ge Y; Xu B; Cai H; Jing W; Ouyang Q; Yuan Q; Li X; Fan Y; Shen Y; Shi Q; Wang Q; Cui L; Yin X; Ma G
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2301-2310. PubMed ID: 36198834
[TBL] [Abstract] [Full Text] [Related]
[Next]
